Sensifai Health

Company Overview

Snapshot

Founded in May 2024 by Amir Hadid, Emily Mcdonald, and Dennis Jensen, Sensifai Health operates with 1–10 employees. The company secured its seed funding round in July 2025, with Glen Ventures participating as a lead investor.

Business overview

Sensifai Health is a Health Tech startup specializing in bioconvergence, leveraging AI to translate physiological data from wearable biometric sensors into actionable immunological insights. The company's core technology focuses on the early detection of systemic inflammation in individuals with chronic conditions, aiming to facilitate timely medical interventions and improve health outcomes. Sensifai Health operates within the Health Tech & Life Sciences sector, specifically in Digital Healthcare, and employs a B2B business model.

Company Intelligence Q&A

What is Sensifai Health's primary focus?

Sensifai Health focuses on bioconvergence, using AI to interpret physiological data from wearable biometric sensors to provide immunological insights for early detection of systemic inflammation in individuals with chronic conditions.

When was Sensifai Health founded?

Sensifai Health was founded in May 2024.

Who are the founders of Sensifai Health?

The founders of Sensifai Health are Amir Hadid, Emily Mcdonald, and Dennis Jensen.

What is the current operational status of Sensifai Health?

Sensifai Health is currently non-active, having ceased to operate in January 2026.

Which investor participated in Sensifai Health's funding round?

In July 2025, Glen Ventures participated as a lead investor in.